One of the longest storylines in WWE is the one involving The Bloodline. Throughout the Bloodline storyline, the faction ...

The former Kate Middleton was diagnosed with cancer early in 2024, and much speculation about the state of her health has followed. Catherine, Princess of Wales, has since shared that she ...

WWE's Bloodline story should have been a star-making vehicle for Solo Sikoa, but his feud with Roman Reigns ruined him.

Roman Reigns was the undisputed biggest name in professional wrestling. From the Bloodlines storyline, to his comeback from cancer, to his place at the top of World Wrestling Entertainment’s card, ...

Roman Reigns will enter in the Men's Royal Rumble match 2025. [Image credits: WWE's X account and official website] Roman Reigns is now the rightful holder of the Ula Fala, having defeated Solo ...

If you could take a simple blood test that could detect multiple types of cancer while they’re still in an early and treatable stage, would you? For many, the answer would be a resounding yes.

Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer. Two new studies led by ...

A drug currently in clinical trials for breast cancer shows potential in treating blood cancers, specifically myeloproliferative neoplasms (MPNs) and acute myeloid leukemia (AML).

The investigational drug PMD-026 is a pan-RSK inhibitor in that it blocks all four versions of the protein - RSK1, RSK2, RSK3 and RSK4. In breast cancer, the evidence suggests that PMD-026 may ...

Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of several forms of blood cancer using a drug ...

Research from WashU Medicine found a possible new treatment strategy for certain types of blood cancers. The bone marrow of a mouse with a myeloproliferative neoplasm (left) shows fibrosis ...

Despite the availability of several noninvasive tests for colorectal cancer, prioritizing blood-based tests may result in higher costs and worse population-level outcomes. In a federally qualified ...